Compound information
- Natural Products
- ZC587441
- Molecular Formula
- C15H22N2O4S
- Molecular Weight
- 326.130028184 g/mol
- Structure
-
- IUPAC Name
- tert-butyl 4-(benzenesulfonyl)piperazine-1-carboxylate
- InChI
- InChI=1S/C15H22N2O4S/c1-15(2,3)21-14(18)16-9-11-17(12-10-16)22(19,20)13-7-5-4-6-8-13/h4-8H,9-12H2,1-3H3
- InChI Key
- HIRAJISWISWCGQ-UHFFFAOYSA-N
- SMILES
- CC(C)(C)OC(=O)N1CCN(S(=O)(=O)c2ccccc2)CC1
- Source
- ZINC000006563378
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 22 | Ring Count | 2 |
Heteroatom Count | 7 | Rotatable Bond Count | 2 |
Hydrogen Bond Acceptor Count | 4 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 66.92 Å2 | LogP | 2.246 |
LogS | -2.921 | LogD | 3.205 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.045 | Pgp substrate | 0.014 |
HIA | 0.965 | F20 % | 0.98 |
F30 % | 0.947 | Caco-2 | -4.501 |
MDCK | -4.655 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.775 | PPB | 86.552 |
VD | 1.594 | Fu | 0.685 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.029 | CYP1A2 substrate | 0.388 |
CYP2A6 substrate | 0.75 | CYP2B6 substrate | 0.764 |
CYP2C19 inhibitor | 0.881 | CYP2C19 substrate | 0.76 |
CYP2C8 substrate | 0.581 | CYP2C9 inhibitor | 0.106 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.026 |
CYP2D6 substrate | 0.727 | CYP2E1 substrate | 0.92 |
CYP3A4 inhibitor | 0.037 | CYP3A4 substrate | 0.997 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.599 | CL | 6.355 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.538 | Hepatotoxicity | 0.987 |
Mutagenicity | 0.22 | Rat Oral Acute Toxicity | 0.237 |
FDAMDD | 0.093 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.962 | Eye Corrosion | 0.01 |
Eye Irritation | 0.262 | Respiratory Toxicity | 0.366 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.766 | IGC50 | 2.982 |
LC50FM | 2.663 | LC50DM | 3.427 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.23 | NR-AR-LBD | 0.326 |
NR-AhR | 0.033 | NR-Aromatase | 0.12 |
NR-ER | 0.238 | NR-ER-LBD | 0.375 |
NR-PPAR-gamma | 0.108 | SR-ARE | 0.692 |
SR-ATAD5 | 0.388 | SR-HSE | 0.087 |
SR-MMP | 0.016 | SR-p53 | 0.025 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.